BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marinelli L, Tenore GC, Novellino E. Probiotic species in the modulation of the anticancer immune response. Semin Cancer Biol. 2017;46:182-190. [PMID: 28844794 DOI: 10.1016/j.semcancer.2017.08.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Machado D, Almeida D, Seabra CL, Andrade JC, Gomes AM, Freitas AC. Nanoprobiotics: When Technology Meets Gut Health. In: Thangadurai D, Sangeetha J, Prasad R, editors. Functional Bionanomaterials. Cham: Springer International Publishing; 2020. pp. 389-425. [DOI: 10.1007/978-3-030-41464-1_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Pimentel TC, Aparecida Marcolino V, Eduardo Barão C, Jensen Klososki S, Rosset M. Minas Frescal Cheese as a Probiotic Carrier. In: Merillon J, Ramawat KG, editors. Sweeteners. Cham: Springer International Publishing; 2017. pp. 1-32. [DOI: 10.1007/978-3-319-54528-8_66-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
3 Shui L, Yang X, Li J, Yi C, Sun Q, Zhu H. Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy.Front Immunol. 2019;10:2989. [PMID: 32010123 DOI: 10.3389/fimmu.2019.02989] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
4 Li N, Yu Y, Chen X, Gao S, Zhang Q, Xu C. Bifidobacterium breve M-16V alters the gut microbiota to alleviate OVA-induced food allergy through IL-33/ST2 signal pathway. J Cell Physiol 2020;235:9464-73. [PMID: 32394447 DOI: 10.1002/jcp.29751] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Li F, Lu D, Zhong Q, Tan F, Li W, Liao W, Zhao X. Lactobacillus fermentum HFY06 reduced CCl 4 -induced hepatic damage in Kunming mice. RSC Adv 2020;10:1-9. [DOI: 10.1039/c9ra08789c] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
6 Xu F, Yi J, Wang F, Wang W, Wang Z, Xue J, Luan X. Involvement of soluble B7-H3 in combination with the serum inflammatory cytokines interleukin-17, -8 and -6 in the diagnosis of hepatocellular carcinoma. Oncol Lett 2017;14:8138-43. [PMID: 29344257 DOI: 10.3892/ol.2017.7215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
7 Adachi K, Tamada K. Microbial biomarkers for immune checkpoint blockade therapy against cancer. J Gastroenterol 2018;53:999-1005. [PMID: 30003334 DOI: 10.1007/s00535-018-1492-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
8 Szczyrek M, Bitkowska P, Chunowski P, Czuchryta P, Krawczyk P, Milanowski J. Diet, Microbiome, and Cancer Immunotherapy-A Comprehensive Review. Nutrients 2021;13:2217. [PMID: 34203292 DOI: 10.3390/nu13072217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xin M, Xie Q, Ma L, An G, Xiao J, Li J, Liu X, Gao P, Liang J, Li Y. Synergistic anti-tumour effects of Clostridium butyricum in combination with apatinib in CT26 colorectal tumour-bearing mice. Anticancer Drugs 2019;30:991-7. [PMID: 31205067 DOI: 10.1097/CAD.0000000000000817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Fontana L, Plaza-Díaz J, Robles-Bolívar P, Valente-Godínez H, Sáez-Lara MJ, Abadía-Molina F, Gómez-Llorented C, Gil Á, Álvarez-Mercado AI. Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 Modulate Macrophage Gene Expression and Ameliorate Damage Markers in the Liver of Zucker-Lepr fa/fa Rats. Nutrients 2021;13:202. [PMID: 33440736 DOI: 10.3390/nu13010202] [Reference Citation Analysis]
11 Cianci R, Franza L, Schinzari G, Rossi E, Ianiro G, Tortora G, Gasbarrini A, Gambassi G, Cammarota G. The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer. Int J Mol Sci 2019;20:E501. [PMID: 30682772 DOI: 10.3390/ijms20030501] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
12 Shen W, Sun J, Li Z, Yao F, Lin K, Jiao X. Food intake and its effect on the species and abundance of intestinal flora in colorectal cancer and healthy individuals. Korean J Intern Med 2021;36:568-83. [PMID: 33167104 DOI: 10.3904/kjim.2019.373] [Reference Citation Analysis]
13 Wang L, Ma Q, Yao R, Liu J. Current status and development of anti-PD-1/PD-L1 immunotherapy for lung cancer. International Immunopharmacology 2020;79:106088. [DOI: 10.1016/j.intimp.2019.106088] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
14 Aindelis G, Chlichlia K. Modulation of Anti-Tumour Immune Responses by Probiotic Bacteria. Vaccines (Basel) 2020;8:E329. [PMID: 32575876 DOI: 10.3390/vaccines8020329] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
15 Wang Z, Wu X. Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blocker. Cancer Med 2020;9:8086-121. [PMID: 32875727 DOI: 10.1002/cam4.3410] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
16 Sidhu JS, Alkandari D. Overview of probiotics in cancer prevention and therapy. Functional Foods in Cancer Prevention and Therapy. Elsevier; 2020. pp. 261-82. [DOI: 10.1016/b978-0-12-816151-7.00014-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Silveira DSC, Veronez LC, Lopes-Júnior LC, Anatriello E, Brunaldi MO, Pereira-da-Silva G. Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model. World J Gastroenterol 2020; 26(43): 6782-6794 [PMID: 33268961 DOI: 10.3748/wjg.v26.i43.6782] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
18 Yu W, Si M, Li L, He P, Fan Z, Zhang Q, Jiao X. Biomarkers Reflecting The Destruction Of The Blood-Brain Barrier Are Valuable In Predicting The Risk Of Lymphomas With Central Nervous System Involvement. Onco Targets Ther 2019;12:9505-12. [PMID: 31807026 DOI: 10.2147/OTT.S222432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Chen B, Du G, Guo J, Zhang Y. Bugs, drugs, and cancer: can the microbiome be a potential therapeutic target for cancer management? Drug Discov Today 2019;24:1000-9. [PMID: 30818030 DOI: 10.1016/j.drudis.2019.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
20 Lee MH. Harness the functions of gut microbiome in tumorigenesis for cancer treatment. Cancer Commun (Lond) 2021. [PMID: 34355542 DOI: 10.1002/cac2.12200] [Reference Citation Analysis]
21 Chattopadhyay I, Nandi D, Nag A. The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy. Semin Cancer Biol 2021;70:98-111. [PMID: 32739479 DOI: 10.1016/j.semcancer.2020.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Nicoletti A, Pompili M, Gasbarrini A, Ponziani FR. Going with the gut: probiotics as a novel therapy for hepatocellular carcinoma. Hepatobiliary Surg Nutr 2019;8:295-7. [PMID: 31245418 DOI: 10.21037/hbsn.2019.01.16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Andreeva NV, Gabbasova RR, Grivennikov SI. Microbiome in cancer progression and therapy. Curr Opin Microbiol 2020;56:118-26. [PMID: 33147555 DOI: 10.1016/j.mib.2020.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Shen W, Sun J, Yao F, Lin K, Yuan Y, Chen Y, Han H, Li Z, Zou J, Jiao X. Microbiome in Intestinal Lavage Fluid May Be A Better Indicator in Evaluating The Risk of Developing Colorectal Cancer Compared with Fecal Samples. Transl Oncol 2020;13:100772. [PMID: 32298987 DOI: 10.1016/j.tranon.2020.100772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Liu K, Yang X, Zeng M, Yuan Y, Sun J, He P, Sun J, Xie Q, Chang X, Zhang S, Chen X, Cai L, Xie Y, Jiao X. The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer. Dis Markers 2021;2021:1171239. [PMID: 34853619 DOI: 10.1155/2021/1171239] [Reference Citation Analysis]
26 Xiaoyu P, Chao G, Lihua D, Pengyu C. Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not?. Gut Microbes 2020;11:691-705. [PMID: 32216675 DOI: 10.1080/19490976.2020.1739794] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Reens AL, Cabral DJ, Liang X, Norton JE Jr, Therien AG, Hazuda DJ, Swaminathan G. Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination. Front Immunol 2021;12:643255. [PMID: 34054810 DOI: 10.3389/fimmu.2021.643255] [Reference Citation Analysis]